What is Therabody?
Founded by Dr. Jason Wersland, Therabody originated with the invention of the Theragun, a device designed to address chronic pain through percussive therapy. Since its inception, the company has evolved into a multifaceted wellness enterprise. Its current portfolio extends well beyond hardware, encompassing a sophisticated ecosystem of digital content, proprietary software, and biometric monitoring tools. This strategic diversification allows the company to address the holistic needs of the body and mind, moving beyond simple muscle recovery to provide comprehensive health management solutions. By maintaining a focus on evidence-based wellness, Therabody has established a robust market position that bridges the gap between clinical-grade recovery technology and consumer-accessible health devices.
How much funding has Therabody raised?
Therabody has raised a total of $165M across 1 funding round:
Private Equity
$165M
Private Equity (2022): $165M with participation from Rx3 Ventures, North Castle Partners, and Hartbeat Ventures
Key Investors in Therabody
Rx3 Ventures
A consumer-focused investment fund that leverages a unique network of partners and influencers to accelerate brand growth in the lifestyle, sports, and entertainment sectors.
North Castle Partners
A private equity firm specializing in the health, wellness, and active living markets, providing strategic guidance to entrepreneurs navigating complex growth stages.
Hartbeat Ventures
An investment firm focused on high-growth opportunities, often aligning with brands that possess strong cultural resonance and market-disrupting potential.
What's next for Therabody?
With the recent influx of capital, Therabody is expected to focus on deepening its technological moat through enhanced biometric integration and software-driven personalization. The company is likely to prioritize the expansion of its digital ecosystem, which serves as a recurring revenue stream and a mechanism for long-term user engagement. Furthermore, the strategic backing from specialized consumer-focused firms suggests a continued emphasis on brand scaling and market penetration within the global health and wellness sector. As the company navigates this growth phase, the focus will remain on maintaining its category-defining status while scaling its operations to meet the increasing demand for integrated, data-backed recovery solutions.
See full Therabody company page
